Beckman to Buy Dako's Flow Cytometry Business

Nov 19, 2007

NEW YORK (GenomeWeb News) – Beckman Coulter today said it will buy the flow cytometry business of Dako for an undisclosed sum.

Included in the acquisition are Dako’s MoFlo XDP cell sorter and the CyAn research flow cytometer.

Beckman President and CEO Scott Garrett said the addition of these tools and assets to its flow cytometry line allows it to offer “a more comprehensive range of research solutions to our customers.”

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Breaking News

The Scan

Best Options

The Seattle Times writes that pharmacogenomics testing can help choose medications that may work best for people with depression.

A Butterfly's Wings

Researchers report that deleting one gene from butterflies affects their wing coloration patterns, according to the Washington Post.

This Week in PNAS

In PNAS this week: genome sequencing of weevil symbionts, retinoid X receptor deletion in lung cancer metastasis, and more.

Pathogen Tracking

Sequencing could help combat foodborne illnesses, according to a blog post by Food and Drug Administration officials.

Main menu